
1. mmwr recomm rep. 2009 feb 6;58(rr-2):1-25.

prevention rotavirus gastroenteritis among infants children:
recommendations advisory committee immunization practices (acip).

cortese mm(1), parashar ud; centers disease control prevention (cdc).

author information: 
(1)division viral diseases, national center immunization respiratory
diseases, atlanta ga 30333, usa. mcortese@cdc.gov

erratum in
    mmwr recomm rep. 2010 aug 27;59(33):1074.

rotavirus common cause severe gastroenteritis infants young
children worldwide. initiation rotavirus vaccination program the
united states 2006, approximately 80% u.s. children rotavirus
gastroenteritis age 5 years. year 1990s early 2000s,
rotavirus resulted approximately 410,000 physician visits, 205,000272,000
emergency department visits, 55,00070,000 hospitalizations among u.s. infants
and children, total annual direct indirect costs approximately $1
billion. february 2006, live, oral, human-bovine reassortant rotavirus
vaccine (rotateq(r) [rv5]) licensed 3-dose series use among u.s.
infants prevention rotavirus gastroenteritis, advisory
committee immunization practices (acip) recommended routine use rv5 among
u.s. infants (cdc. prevention rotavirus gastroenteritis among infants and
children: recommendations advisory committee immunization practices
[acip]. mmwr 2006;55[no. rr-12]). april 2008, live, oral, human attenuated
rotavirus vaccine (rotarix(r) [rv1]) licensed 2-dose series use
among u.s. infants, june 2008, acip updated rotavirus vaccine
recommendations include use rv1. report updates replaces 2006 
acip statement prevention rotavirus gastroenteritis. acip recommends
routine vaccination u.s. infants rotavirus vaccine. rv5 rv1 differ in
composition schedule administration. rv5 administered orally a
3-dose series, doses administered ages 2, 4, 6 months. rv1 be
administered orally 2-dose series, doses administered ages 2 4
months. acip express preference either rv5 rv1. the
recommendations report also address maximum ages doses,
contraindications, precautions, special situations administration 
rotavirus vaccine.


pmid: 19194371  [indexed medline]

